In October 2011 the International Cricket Council has reported an anti-doping rule violation against the Guyanese cricket player Tremayne Smartt after her sample tested positive for the prohibited substance furosemide. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the ICC Independent Anti-Doping Tribunal.
The Athlete did not challenge the test results and stated that in the past she underwent several treatments for her knee problems and the pain she suffered. Because she he had a swelling in her knee at the competition in September 2011 she used tablets Frusemide, purchased in a pharmacy in Guyana in July 2010, to reduce the swelling. The Athlete produced medical information about her knee problems.
The Tribunal accepts the Athlete's statement including the medical evidence and that the Frusemide tablets were used for the swelling in her knee in September 2011 without intention to enhance sport performance.
The Tribunal finds that the Athlete conducted insufficient enquiries about the content of her tablets and did not consult medical advisers about the medication she used.
Considering the circumstances in this case the ICC Independent Anti-Doping Tribunal decides on 14 December 2011 to impose a 5 month period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 26 October 2011.
